These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 7208342

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
    Saklamaz A, Comlekci A, Temiz A, Caliskan S, Ceylan C, Alacacioglu A, Yesil S.
    Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299
    [Abstract] [Full Text] [Related]

  • 23. [Influence of lovastatin on serum lipids in patients with primary hyperlipidemia and phenotype IIa and IIB. II. Changes of lipid composition of plasma lipoprotein fractions after lovastatin administration].
    Idzior-Waluś B.
    Przegl Lek; 1992 May; 49(10):327-33. PubMed ID: 1308286
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb.
    Madej A, Okopien B, Kowalski J, Zielinski M, Wysocki J, Szygula B, Kalina Z, Herman ZS.
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):345-9. PubMed ID: 9660044
    [Abstract] [Full Text] [Related]

  • 26. Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.
    Saougos VG, Tambaki AP, Kalogirou M, Kostapanos M, Gazi IF, Wolfert RL, Elisaf M, Tselepis AD.
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2236-43. PubMed ID: 17656665
    [Abstract] [Full Text] [Related]

  • 27. [Pleiotropic effects of micronized fenofibrate in patients with combined hyperlipidemia].
    Okopień B, Cwalina Ł, Haberka M, Kowalski J, Zieliński M, Szwed Z, Kalina Z, Herman ZS.
    Pol Merkur Lekarski; 2002 Dec; 13(78):465-9. PubMed ID: 12666442
    [Abstract] [Full Text] [Related]

  • 28. [Efficacy of bezafibrate and fenofibrate on elevated blood lipids in HLP type IIa, IIb and IV].
    Schwartzkopff W, Luley C, Scheffler W, Lehmann-Leo W, Schilling A, Wegscheider K.
    Med Welt; 1982 Apr 30; 33(17):631-7. PubMed ID: 7098826
    [No Abstract] [Full Text] [Related]

  • 29. Fenofibrate for the treatment of type IV and V hyperlipoproteinemias: a double-blind, placebo-controlled multicenter US study.
    Goldberg AC, Schonfeld G, Feldman EB, Ginsberg HN, Hunninghake DB, Insull W, Knopp RH, Kwiterovich PO, Mellies MJ, Pickering J.
    Clin Ther; 1989 Apr 30; 11(1):69-83. PubMed ID: 2655907
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effectiveness of a fenofibrate 145-mg nanoparticle tablet formulation compared with the standard 160-mg tablet in patients with coronary heart disease and dyslipidemia.
    Maciejewski S, Hilleman D.
    Pharmacotherapy; 2008 May 30; 28(5):570-5. PubMed ID: 18447655
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)].
    Rouffy J, Chanu B, Bakir R, Goy-Loepper J, Saya C.
    Nouv Presse Med; 1980 Oct 30; 9(40):3014-7. PubMed ID: 7443443
    [Abstract] [Full Text] [Related]

  • 36. Effect of fenofibrate on apolipoprotein B containing lipoprotein particles.
    Fruchart JC, Bard JM, Fievet C, Kandoussi A, Slimane M, Douste-Blazy P.
    Prog Clin Biol Res; 1988 Oct 30; 255():305-10. PubMed ID: 3277201
    [No Abstract] [Full Text] [Related]

  • 37. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
    Ceska R, Sobra J, Kvasnicka J, Procházková R, Kvasilová M, Haas T.
    Cas Lek Cesk; 1996 Jul 26; 135(13):413-6. PubMed ID: 8925538
    [Abstract] [Full Text] [Related]

  • 38. Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).
    Grundy SM, Vega GL, Yuan Z, Battisti WP, Brady WE, Palmisano J.
    Am J Cardiol; 2005 Feb 15; 95(4):462-8. PubMed ID: 15695129
    [Abstract] [Full Text] [Related]

  • 39. [Examination of cortisol and insulin levels in serum of patients with primary hyperlipoproteinemia and phenotype IIa and IIb during lovastatin treatment].
    Idzior-Waluś B.
    Przegl Lek; 1992 Feb 15; 49(11):365-8. PubMed ID: 1306568
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.